Status:
UNKNOWN
Long Study - Longitudinal Thrombosis in End Stage Renal Disease
Lead Sponsor:
Hamilton Health Sciences Corporation
Collaborating Sponsors:
Canadian Institutes of Health Research (CIHR)
Conditions:
End Stage Renal Disease
Thrombosis
Eligibility:
All Genders
18+ years
Brief Summary
The primary focus of this study is to collect information through diagnostic testing, blood sample analysis and patient data collection on patients starting hemodialysis to determine risk and preventa...
Detailed Description
Hemodialysis patients have a very high rate of heart attacks, strokes and amputation. These problems are caused by a blood vessel problem called atherosclerosis (hardening of the arteries), and by clo...
Eligibility Criteria
Inclusion
- Adult patient (aged \> 18 years)
- Patient on hemodialysis between 30 and 90 days
Exclusion
- Anticipated recovery of renal function (on dialysis \< 90 days)
- Critical illness at time of recruitment (patients who are critically ill \[ICU\] when first screened, who survive to 80 days, will be rescreened and will be able to participate at that point if no longer critically ill)
- Planned live-donor renal transplant within 6 months
- Patient cannot consent due to language barrier
- Patient cannot consent due to cognitive difficulties
- Patient cannot consent due to hearing impairment
- Patient cannot consent due to speech impairment
- Patient or decision maker declines consent
- Patient is unable to give consent and no substitute decision maker is available
- Patient on dialysis longer than 90 days
Key Trial Info
Start Date :
July 1 2004
Trial Type :
OBSERVATIONAL
Allocation :
ESTIMATED
End Date :
December 1 2008
Estimated Enrollment :
400 Patients enrolled
Trial Details
Trial ID
NCT00157664
Start Date
July 1 2004
End Date
December 1 2008
Last Update
June 17 2008
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
St. Joseph's Hospital
Hamilton, Ontario, Canada, L8N 4A6